A. Postexertional neuroimmune exhaustion
|
Matching
|
8
|
53.3
|
1
|
16.7
|
–
|
9
|
40.9
|
2
|
20.0
|
4
|
23.5
|
6
|
16.2
|
15
|
25.4
|
Ambiguous/other
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
B. Neurological impairments
|
Matching
|
12
|
80.0
|
6
|
100
|
1
|
19
|
86.4
|
18
|
90.0
|
15
|
88.3
|
33
|
89.2
|
52
|
88.1
|
Ambiguous/other
|
11
|
73.3
|
2
|
33.3
|
1
|
14
|
63.6
|
17
|
85.0
|
14
|
82.4
|
31
|
83.8
|
45
|
76.3
|
Ambiguous/other B1–B4
|
3
|
20.0
|
1
|
16.7
|
1
|
5
|
22.7
|
11
|
55.0
|
6
|
35.3
|
17
|
45.9
|
22
|
37.3
|
Speech/language
|
7
|
46.7
|
2
|
33.3
|
1
|
10
|
45.5
|
11
|
55.0
|
9
|
52.9
|
20
|
54.1
|
30
|
50.8
|
Consciousness
|
5
|
33.3
|
–
|
–
|
–
|
5
|
22.7
|
5
|
25.0
|
3
|
17.6
|
8
|
21.6
|
13
|
22.0
|
C. Immune, gastrointestinal, genitourinary impairments
|
Matching
|
3
|
20.0
|
–
|
–
|
–
|
3
|
13.6
|
6
|
30.0
|
4
|
23.5
|
9
|
24.3
|
12
|
20.3
|
Ambiguous/other
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
D. Energy production/transportation impairments
|
Matching
|
8
|
53.3
|
3
|
50.0
|
–
|
11
|
50.0
|
7
|
35.0
|
2
|
11.8
|
9
|
24.3
|
20
|
33.9
|
Ambiguous/other
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
2
|
10.0
|
–
|
–
|
2
|
5.4
|
2
|
3.4
|
Mood/behavior
|
Matching
|
2
|
13.3
|
1
|
16.7
|
–
|
3
|
13.6
|
2
|
10.0
|
3
|
17.6
|
5
|
13.5
|
8
|
13.6
|
Ambiguous/other
|
6
|
40.0
|
–
|
–
|
–
|
6
|
27.3
|
4
|
20.0
|
3
|
17.6
|
7
|
18.9
|
13
|
22.0
|
Uncategorized d-la symptoms
|
|
Metabolic acidosis
|
15
|
100
|
6
|
100
|
1
|
22
|
100
|
20
|
100
|
16
|
94.1
|
36
|
97.3
|
58
|
98.3
|
|
Other abnormalities
|
4
|
26.7
|
–
|
–
|
–
|
4
|
18.2
|
6
|
30.0
|
2
|
11.8
|
7
|
18.9
|
11
|
18.6
|